"Molecular Immunity: A Chronology of 60-Years of Discovery," a Book by Kendall A. Smith from Oasis Publishers

"Molecular Immunity: A Chronology of 60-Years of Discovery," a Book by Kendall A. Smith from Oasis Publishers

Kendall A. Smith, M.D. is a professor of Medicine and Immunology in the Weil Medical College of Cornell University. Dr. Smith undertook clinical training in Medicine at Yale-New Haven Hospital. Subsequently, his unswerving focus led him to pursue an investigative career, which was pivoted on... - November 10, 2018 - Oasis Publishers

Simplicity in Complexity: Ian James Martins’ Research on Insulin Therapy and Autoimmune Disease with a Special Focus on NAFLD from Oasis Publishers

Simplicity in Complexity: Ian James Martins’ Research on Insulin Therapy and Autoimmune Disease with a Special Focus on NAFLD from Oasis Publishers

The insightful research by Ian James Martin might be one of the next breakthroughs in medical science. His research paper describes the insulin therapy and the autoimmune disease with relevance to non-alcoholic fatty liver disease. It is a well-known fact that the diabetes epidemic is now expected... - November 06, 2018 - Oasis Publishers

Standigm Launches Artificial Intelligence-Driven Lead Optimization Service at BIO-Europe 2018 in Copenhagen, Denmark

Standigm, a company using the advanced AI technology to drug discovery, launched the customized lead optimization service, "Standigm BEST®," at BIO-Europe 2018 in Copenhagen, Denmark. Standigm BEST® provides AI-driven lead optimization and can also be utilized for fast-follow hit identification or patent fencing strategy. One-to-one meetings have been scheduled with leading pharmaceutical companies, indicating their interest in Standigm BEST®. - November 05, 2018 - Standigm

Bad Cholesterol May be Our Best Friend by Uffe Ravnskov from Oasis Publishers

Bad Cholesterol May be Our Best Friend by Uffe Ravnskov from Oasis Publishers

Uffe Ravnskov and his team from Oasis Publishers announces ground-breaking research findings that counters the basic argument or general belief that bad cholesterol leads to heart diseases. Cholesterol is a fatty lipid found in all cells in our body and it is vital for the normal functioning of... - November 03, 2018 - Oasis Publishers

A New Way to Treat Diseases Using Ou MC Decrescendo Phenomenon by Ming Cheh Ou from Oasis Publishers

Dr. Ming Cheh Ou et al from Oasis Publishers has introduced a new way to treat diseases using Ou MC Decrescendo Phenomenon. Manual therapy is a clinical approach that uses therapeutic touch or different hands-on techniques to reduce pain, increase the range of motion, and reduce or eliminate soft... - October 24, 2018 - Oasis Publishers

Introducing Imported Cure-All-Ills Wax-Free Brown Rice by Shaw Watanabe from Oasis Publishers

Introducing Imported Cure-All-Ills Wax-Free Brown Rice by Shaw Watanabe from Oasis Publishers

Dr. Shaw Watanabe from Oasis Publishers has introduced a new Cure-all-Ills Wax-free Brown Rice. Who would have imagined – “Food as Medicine,” but the newly developed concept of Better Low Protein Brown Rice and Wax-free Brown Rice, the two new types of high-grade, dietary-rich... - October 24, 2018 - Oasis Publishers

The Next Generation Technology for Light Emitting Displays by Louzhen Fan from Oasis Publishers

Louzhen Fan from Oasis Publishers has invented a next-generation technology for Light Emitting Diodes. Quantum dots have emerged as the next-generation technology for Light Emitting Diodes (LEDs) used in lighting and displays. These materials emit pure, saturated color that can be tuned simply by... - October 23, 2018 - Oasis Publishers

Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)

Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the... - October 21, 2018 - Epitope Diagnostics, Inc.

OmicsLogic Bioinformatics Training Program Offered Through Louisiana Biomedical Research Network (LBRN)

OmicsLogic Bioinformatics Training Program Offered Through Louisiana Biomedical Research Network (LBRN)

LBRN (Louisiana Biomedical Research Network) together with Pine Biotech and the Tauber Bioinformatics Research Center from the University of Haifa, Israel have established a bioinformatics training program “OmicsLogic,” a comprehensive collection of modular resources in data science and molecular biology. The program emphasizes hands-on learning with relevant clinical and research examples. - October 18, 2018 - Pine Biotech

Breakthrough Research on Heat Production in Skeletal Muscles by Dr. Frank Diederichs from Oasis Publishers

Dr. Frank Diederichs from Oasis Publishers has done outstanding research on Heat Production in Skeletal muscles using Chemical Thermodynamic Principles. Skeletal muscles are composed of special cells, the muscle fibers, which ‑ on the basis of a coupled reaction ‑ can generate... - October 16, 2018 - Oasis Publishers

Nancyclotep is Positioning Itself to Become the Reference Center for Vectorized Internal Radiotherapy in the Greater East Region

Nancyclotep, a provider of solutions for the transfer of radiopharmaceuticals to the clinical setting, has announced its intention to become the reference center for Vectorized Internal Radiotherapy for the Greater East region, in collaboration with the University Hospital of Nancy and the support... - October 12, 2018 - Nancyclotep

HR2 Research/Analytics Recognized as a 4.7 Star Rated Employer by Indeed.com

HR2 Research/Analytics, Bellevue’s award-winning, local primary research firm, is pleased to announce its recognition as a current 4.7 star rating as one of the best employers by the leading job site, Indeed.com. - October 01, 2018 - HR2 Research and Analytics

Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth

Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. This program will allow Epitope Diagnostics... - September 23, 2018 - Epitope Diagnostics, Inc.

Emergent 121 Coaching to Host 2-Day Workshop for Women

Emergent 121 Coaching announces it will be hosting a two-day workshop for women, entitled Life on Purpose. The event is being held at The Fig Room, in Jacksonville Beach, FL, on October 25th and 26th, 2018. Rooted in the values of dignity and love, Emergent 121 Coaching offers professional life... - September 18, 2018 - Emergent Resource Solutions, LLC

Perimeter Medical Imaging Inc Appoints Charles S. Carignan, MD as New CEO

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the appointment of Charles S. Carignan, MD as CEO. Dr. Carignan has more than 20 years of experience in key leadership positions spanning the medical imaging,... - June 26, 2018 - Perimeter Medical Imaging Inc

BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® ELISA Calprotectin Test

BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 14, 2018 - BUHLMANN Diagnostics Corp

Joint Resolution Passes NJ Senate as NJ Center for Tourette Syndrome Celebrates Tourette Awareness at the State House

Members of the Senate and General Assembly helped NJCTS recognize Youth Scholarship winners, Youth Advocates of the Year and top fundraisers in a ceremony prior to the vote. - June 13, 2018 - New Jersey Center for Tourette Syndrome

Occam Technology Group Becomes a Google Cloud Partner to Deliver LPWAN-Focused Solutions for IoT Applications

Occam Technology Group, a full-service global contract engineering design and development firm located in Tampa Bay, today announced its collaboration with Google Cloud and is now offering the OccamSmart Network Server Stack for LoRaWAN on Google Cloud Platform. - June 09, 2018 - Occam Technology Group

Perthera to Exhibit at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Perthera to Exhibit at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Perthera, Inc., the leading Therapeutics Intelligence Company™, is attending the 2018 ASCO Annual Meeting at McCormick Place, Chicago, IL, June 1-5, 2018. Perthera science and clinical results will be represented in a Podium Presentation, 2 Poster Presentations and a Symposium Breakfast. - May 30, 2018 - Perthera, Inc.

Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting

Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting

Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be... - May 22, 2018 - Perthera, Inc.

Mercodia Launches Unique Quality System

Mercodia Launches Unique Quality System

The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB

NJ Center for Tourette Syndrome Reappoints Tim Howard as Member of Board of Directors

Soccer star Tim Howard to serve on NJCTS board of directors for two more years. - May 17, 2018 - New Jersey Center for Tourette Syndrome

Billions in Global Wound Product Sales, Yet Chronic Wounds Remain a Chronic Problem, Based on New Research from MedMarket Diligence

Billions in Global Wound Product Sales, Yet Chronic Wounds Remain a Chronic Problem, Based on New Research from MedMarket Diligence

Despite the legion of products developed for wound care, from dressings to negative pressure wound therapy to bioengineered skin and growth factors, the obesity- and age-driven increase in chronic slow-healing and non-healing wounds plague healthcare systems globally. Research and routine clinical practice have advanced the science to better understand and address chronic wounds, but much work remains for research and manufacturing to impact the growing caseload. - April 10, 2018 - MedMarket Diligence, LLC

NJ Center for Tourette Syndrome Rolls Out New Virtual Walk

NJ Walks for TS supports the various educational programs delivered throughout the state. - March 24, 2018 - New Jersey Center for Tourette Syndrome

Syprosoft Receives Contract to Develop a Software Deployment Package

Syprosoft Receives Contract to Develop a Software Deployment Package

Syprosoft, Inc. announced today the receipt of a contract from a prominent diagnostics company for the development of a software deployment package. This is a long-term client that first retained Syprosoft in the year 2008. Since then Syprosoft has successfully executed on a number of projects... - March 23, 2018 - Syprosoft, Inc.

Perimeter Medical Imaging Appoints Suzanne Foster to Board of Directors

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce that Suzanne Foster, former General Manager of Medtronic Transformative Solutions, will be joining Perimeter’s Board of Directors. Suzanne is a proven business... - March 21, 2018 - Perimeter Medical Imaging Inc

Announcing Support for HELM 2.0 (Hierarchical Editing Language for Macromolecules) in the Open Source Web Editor

Scilligence, a Cambridge, MA-based scientific software company and the Pistoia Alliance, a global alliance of life science companies, vendors, publishers and academic groups, have announced the support of 2.0 in the HELM Web Editor. This update to the web-editor allows scientists to represent structures even when uncertainty is present. This is yet another step forward in standardizing HELM notation and helping scientists represent macromolecules. - March 21, 2018 - Scilligence

IDE Group Launches 2018 Building Better Futures for Health Challenge

IDE Group is working together to find and invest in Australia's best ideas that can make a difference to people's health. Entries are now open for this year's Building Better Futures for Health Challenge and will close Friday, April 20. - March 08, 2018 - IDE Group

Open Health Network Adds Top Medical, Tech Advisors to Board

Open Health Network Adds Top Medical, Tech Advisors to Board

Open Health Network today announced an expansion of its Board of Advisors, adding three members who bring a wealth of scientific, medical and advanced technology leadership to the company. - March 06, 2018 - Open Health Network

Syprosoft Celebrates 15 years; Bolsters Management Team

Syprosoft, Inc. has successfully completed 15 years in business, helping its clients with product development and regulatory compliance. It announced today the appointment of Henry Bryson as Vice President, Business Development. Henry has extensive technical sales experience and previously worked... - March 01, 2018 - Syprosoft, Inc.

OccamSmart Releases Industry First mPCIe Smart Gateway Card for LoRa-Based Networks at Mobile World Congress 2018

OccamSmart showcases its new line of smart solutions for LPWANs at the 2018 GSMA Mobile World Congress in Barcelona, Spain, including world’s first general available mPCIe LoRa Smart Gateway Card. - February 28, 2018 - Occam Technology Group

HR2 Research/Analytics Presents a Research Abstract on Health and Diet News: Seafood from Alaska and the Seafood Supply Chain

HR Squared Research/Analytics has continued to provide research in health food trends, with new studies in wild seafood and the seafood supply chain. Through the use of data analytics and artificial intelligence, HR Squared Research/Analytics has helped major warehouse retailers optimize their spending in the seafood production market. - February 21, 2018 - HR2 Research and Analytics

Perthera Inc. and Blue Faery Announce Their Partnership Against Liver Cancer

Perthera Inc. and Blue Faery Announce Their Partnership Against Liver Cancer

Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual... - February 20, 2018 - Perthera, Inc.

Biosynth Launches the First AquaSpark(TM) Products Stemming from Tel Aviv University Collaboration

AquaSpark™ molecules are the new generation of chemiluminescence probes for research and diagnostic applications. AquaSpark™ probes offer unique advantages as they can work as single agents, they have a higher efficiency and sensitivity over currently existing probes and they are especially designed to work under physiological conditions and can be used ex-vivo and in-vivo. - February 16, 2018 - Biosynth Carbosynth

US Patent Issued on CPSI’s FrostBite™ Pancreas Cancer Cryoablation Catheter

Latest patent covers an endoscopic-based cryocatheter (FrostBite™) designed to provide an advanced approach for targeting pancreatic and other gastroenterological based cancers. - February 15, 2018 - CPSI Biotech

Steven Levy at MD Stem Cells Tapped for International Conference on Biological Information & Biomedical Engineering

Study Director for multiple stem cell studies continues contributions to international scientific community. - February 13, 2018 - MD Stem Cells

Stem Cell Ophthalmology Treatment Study Releases Data on ClinicalTrials.gov Website

MD Stem Cells publishing positive, statistically significant results on treatments in SCOTS. - February 13, 2018 - MD Stem Cells

MD Stem Cells Announces New Spinal Cord Stem Cell Treatment Combined with Exoskeleton and Virtual Reality

MD Stem Cells coordinates latest technologies to advance stem cell treatment of paraplegia. - February 12, 2018 - MD Stem Cells

Patentcloud Provides Even More Patent Insights with AI and UX Upgrades

New upgrades to InQuartik's patent intelligence platform, Patentcloud, are improving the user experience while continuing to deliver patent insights that drive decisions. - February 07, 2018 - InQuartik Co.

Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit

Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.

NewLeaf Symbiotics Receives Second US Patent

Invention provides M-troph products for agricultural applications - January 06, 2018 - Donald Danforth Plant Science Center

SARI Announced It Has Entered Into an Agreement to Acquire the 90% Interests in NMS Group

SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group

SCOTS Eye Stem Cell Study Reports Vision Recovery in Optic Nerve Stroke (NAION); Other Blindness

Stem Cell Ophthalmology Treatment Study in Florida makes progress treating “untreatable” optic nerve and retinal conditions with publication of positive outcomes. - December 29, 2017 - MD Stem Cells

BioStat Solutions, Inc. (BSSI) Announces New Director of Clinical Operations – Eloi Kpamegan, Ph.D.

BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.

Lindorm Announces Joint Venture with ProconsultRJ

Lindorm, a specialist in sediment process studies and manufacturer of the SediMeter™ monitoring instrument, is entering a strategic alliance with ProconsultRJ to provide services and products to the Latin American market. - December 12, 2017 - Lindorm, Inc.

NJCTS Kicks Off 10th Year of Webinars with a Tourette Syndrome Guide for School Nurses on January 24

On January 24, 2018, NJCTS will celebrate the 10th Anniversary milestone with a special webinar geared towards school nurses. - December 07, 2017 - New Jersey Center for Tourette Syndrome

Perthera and ZERO Announce the Decode Your Prostate Cancer Program

Perthera and ZERO Announce the Decode Your Prostate Cancer Program

Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with... - November 28, 2017 - Perthera, Inc.

Perimeter Medical Imaging Appoints Dr. Franklyn Prendergast to Board of Directors

Perimeter Medical Imaging Appoints Dr. Franklyn Prendergast to Board of Directors

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce that Dr. Franklyn Prendergast, will be joining Perimeter’s Board of Directors. Dr. Prendergast spent his entire professional career at Mayo Clinic in Rochester, MN. - November 16, 2017 - Perimeter Medical Imaging Inc

One-Week Intensive Testing of Agricultural Innovation Broker Training Methods

On 23 October, teachers and trainers gathered together for a clear reason: to perfect the agricultural innovation broker training methodology of the CATAlySt consortia. - November 02, 2017 - Discovery R&D Center

Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys

Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys

Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB

Press Releases 251 - 300 of 2,173